poisar

Stocks · News reference

IFF Releases New Report on Consumer Moments in the Era of GLP-1 Medications

International Flavors & Fragrances Inc. has published a new report titled “GLP-1: Moments of Opportunity for the Consumer,” identifying ten emerging consumer consumption moments influenced by the use of GLP-1 medications.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

IFF
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks.Com

    International Flavors (IFF) Expected to Beat Earnings Estimates: Should You Buy?

    International Flavors (IFF) is expected to report Q3 2026 earnings on November 3, with consensus estimates of $0.86 EPS (down 18.1% YoY) and $1.92B in revenues (down 28.9% YoY). Despite declining results, the company has a positive Earnings ESP of +0.97% combined with a Zacks Rank #2 (Buy), suggesting a likely earnings beat. The company has beaten consensus estimates in 3 of the last 4 quarters.

    IFFFUPBY